首页> 外文期刊>Medicinski Glasnik >Screening general practice patients for migraine without aura: construction and validation of the Balkan Migraine Screening Questionnaire (BMSQ)
【24h】

Screening general practice patients for migraine without aura: construction and validation of the Balkan Migraine Screening Questionnaire (BMSQ)

机译:筛查全民患者无先兆偏头痛:巴尔干偏头痛筛查问卷(BMSQ)的构建和验证

获取原文
           

摘要

Aim To develop and validate a screening questionnaire for migrainewithout aura with sufficient diagnostic accuracy to be used inprimary care settings.Methods The study was designed as cross-sectional, multicentric,diagnostic accuracy trial of new questionnaire for screening patientswho visit general practitioners, with an aim to reveal migrainewithout aura. The instrument was constructed for the purpose ofthis study, and validated on the sample of 429 primary care outpatients.The gold standard of diagnosing migraine without aurawas clinical estimate by a neurologist based on the InternationalClassification of Headache Disorders 3rd edition (ICHD-III) criteria.Diagnostic accuracy of the instrument was tested throughconstruction of the Receiver Operator Curve.Results The Balkan Migraine Screening Questionnaire (BMSQ)instrument showed good diagnostic accuracy (sensitivity 83.4%and specificity 79.9%) for migraine without aura, with significantscreening yield among previously undiagnosed patients of 75.9%.The study also confirmed a high percentage of patients with hiddenmigraine without aura (MWA) (52.9%) revealed by the BMSQ andthe ICHD-III criteria that would otherwise remain undiagnosed.Conclusion The BMSQ is a valid and reliable clinical instrumentfor revealing migraine without aura, which could be easily selfadministeredby patients. It has high screening yield, discoveringmajority of patients with previously undiagnosed migraine withoutaura, whose definite diagnosis should later on be confirmedby the attending physicians using the ICHD-III criteria.
机译:目的开发并验证无先兆偏头痛的筛查问卷,该筛查问卷具有足够的诊断准确度,可用于基层医疗机构。方法本研究旨在作为横断面,多中心,诊断准确性的新问卷调查试验,用于筛查访问普通科医生的患者。揭示没有先兆的偏头痛。该仪器是为本研究目的而构建的,并在429名初级保健门诊患者的样本上进行了验证。神经科医生根据国际头痛分类第3版(ICHD-III)标准,对诊断无先兆性偏头痛的金标准进行了临床评估。结果通过巴尔干偏头痛筛查问卷(BMSQ)仪器对无先兆偏头痛的诊断准确性(敏感性为83.4%,特异性为79.9%)显示出良好的诊断准确性,在先前未确诊的患者中筛查率很高。 75.9%。该研究还证实了BMSQ和ICHD-III标准所揭示的无先兆隐匿性偏头痛(MWA)的患者比例很高(52.9%),结论BMSQ是揭示偏头痛的有效且可靠的临床工具没有先兆,患者可以很容易地自我管理。它具有很高的筛查率,可发现大多数先前未被诊断的偏头痛患者,没有先兆,其明确的诊断应随后由主治医师使用ICHD-III标准进行确认。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号